Next Article in Journal
Adjuvant Effect of Cationic Liposomes for Subunit Influenza Vaccine: Influence of Antigen Loading Method, Cholesterol and Immune Modulators
Next Article in Special Issue
The Flux of Phenolic Compounds through Silicone Membranes
Previous Article in Journal
Involvement of Carboxylesterase in Hydrolysis of Propranolol Prodrug during Permeation across Rat Skin
Article

Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice

Department of Life Sciences, Graduate School of Arts and Sciences, The University of Tokyo, 3-8-1 Komaba, Meguro-ku, Tokyo 153-8902, Japan
*
Author to whom correspondence should be addressed.
Pharmaceutics 2013, 5(3), 385-391; https://doi.org/10.3390/pharmaceutics5030385
Received: 8 May 2013 / Revised: 1 July 2013 / Accepted: 3 July 2013 / Published: 11 July 2013
(This article belongs to the Special Issue Advanced Transdermal Drug Delivery)
There is considerable interest in the skin as a site of anti-cancer drug application. Nevertheless, the skin poses a formidable barrier to drug penetration, thereby limiting topical and transdermal bioavailability. However, we previously showed that a thioglycolate-based depilatory agent increases the drug permeability of mouse skin. In the present report, we investigated the skin permeability and efficacy of the anti-cancer drug adriamycin increased when administered transdermally to mice in combination with a thioglycolate-based depilatory agent. Adriamycin in combination with depilatory treatment reduced Ehrlich tumor growth in hairless mice about the weight and size of harvested tumors. In addition, our delivery method for adriamycin increased the therapeutic effectiveness of this agent by decreasing toxicity. Moreover, measurement of adriamycin autofluorescence revealed that topically applied adriamycin penetrate the dermis after depilatory agent treatment. These results indicate that the transdermal delivery of anti-cancer drugs is feasible by handy pretreatment of the skin with a thioglycolate-based depilatory agent. View Full-Text
Keywords: (trans)dermal drug delivery; thioglycolate; adriamycin (trans)dermal drug delivery; thioglycolate; adriamycin
Show Figures

Figure 1

MDPI and ACS Style

Shiozuka, M.; Nonomura, Y.; Matsuda, R. Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice. Pharmaceutics 2013, 5, 385-391. https://doi.org/10.3390/pharmaceutics5030385

AMA Style

Shiozuka M, Nonomura Y, Matsuda R. Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice. Pharmaceutics. 2013; 5(3):385-391. https://doi.org/10.3390/pharmaceutics5030385

Chicago/Turabian Style

Shiozuka, Masataka, Yoshiaki Nonomura, and Ryoichi Matsuda. 2013. "Transdermal Delivery of Adriamycin to Transplanted Ehrlich Ascites Tumor in Mice" Pharmaceutics 5, no. 3: 385-391. https://doi.org/10.3390/pharmaceutics5030385

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop